This inventor holds 0 USPTO granted patents, plus 5 CIPO patents.
Title: Jurgen Eck: Innovator in Biotechnology
Introduction
Jurgen Eck is a notable inventor in the field of biotechnology, based in Germany. He has made significant contributions to the development of innovative solutions for wound care and the production of specialty chemicals. His work reflects a deep understanding of molecular biology and enzymatic processes.
Latest Patents
Jurgen Eck holds patents related to two groundbreaking inventions. The first is a protease for wound conditioning and skin care, identified through molecular cloning from the larvae of Lucilia sericata. This protease, termed debrilase, is designed to aid in the debridement of wounds. The patent describes a nucleic acid molecule encoding a serine protease with the ability to cleave fibrin and casein, along with various related sequences. The second patent involves a novel group of esterases for the enantioselective production of fine and specialty chemicals. This invention includes a polynucleotide encoding an enzyme with carboxylesterase activity, highlighting the potential for innovative applications in chemical production.
Career Highlights
Throughout his career, Jurgen Eck has worked with prominent companies in the biotechnology sector, including B.R.A.I.N. Biotechnology Research and Information Network AG and Brain AG. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in the field.
Collaborations
Jurgen Eck has collaborated with notable colleagues such as Achim Quaiser and Torsten Ochsenreiter. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Jurgen Eck's contributions to biotechnology, particularly in wound care and chemical production, demonstrate his commitment to innovation. His work continues to influence the field and pave the way for future advancements.